MoBiTec to Exhibit at Potsdam Days on Bioanalysis 2018, Taking Place in Potsdam, Germany

The "Potsdam Days on Bioanalysis" provide an excellent platform for researchers, clinicians, and entrepreneurs to discuss diagnostics' hot topics, trends, and recent developments as well as new areas of application and future markets.

Often, the implementation of goal-oriented and profitable cooperations is quite a challenge, in particular when it comes to innovative product developments in the fields of diagnostics and analytics. Typically, challenges lie within finding the right cooperation partners, identifying transfer points and interpreting results for a quick market launch. Cooperations, though, are not only part of developing new products, but also foster creating knowledge, expanding value chains and connecting sales channels. Well-done cooperations cater to both corporate and societal success. Therefore, this event will lead participants along the value chains of analytics and diagnostics. Bringing together all necessary partners in these fields, this opens up opportunities to establish and operate new cooperations.

MoBiTec will, amongst others, inform about products, services, and skills of its partners:

BellBrook Labs is located in Madison Wisconsin, USA. Its mission has been to accelerate drug discovery by providing truly enabling high-throughput screening tools for protein targets. BBL's flagship Transcreener® high-throughput screening (HTS) assays have been used by hundreds of pharmaceutical and biotech companies, CROs and academic laboratories around the world to develop more effective drugs for treating cancer and other debilitating diseases.

Transcreener® - a universal, high-throughput screening platform for enzymes based on direct detection of nucleotide enzyme products with far red FI, FP, and TR-FRET readouts.

"Four Assays Cover Thousands of Target Enzymes".

Transcreener® ADP² Kinase Assay

· Kinase Assays

· ATPase Assays

Transcreener® AMP²/GMP² Phosphodiesterase Assay

· Phosphodiesterase Assays

· Ligase and Synthetase Assays

· Glycosyltransferase Assays

· Methyltransferase Assays

Transcreener® GDP GTPase Assay

· GTPase Assays

· GAP Assays

· GEF Assays

· Glycosyltransferase Assays

Transcreener® UDP² Glycosyltransferase Assay

· Glycosyltransferase Assays

Montana Molecular, located in Bozeman Montana, USA, have developed genetically encoded fluorescent biosensors to measure parameters such as cAMP, DAG, PIP2, Ca2+, and voltage changes in living cells.

How do these live cell assays work?

The principle of the assays is essentially based on single Red and Green Fluorescent Protein sensors, meaning the genetic information for either GFP or RFP linked to an analyte-specific sensor protein domain is introduced into the cells to be investigated. Upon analyte binding to the sensor the fluorescent intensity of GFP or RFP changes which can be easily detected.

Product Applications:

· Fluorescent Biosensors for Live Cell Discovery

· GPCR Biology

· Phosphodiesterase Biology

· Cell Stress & Toxicity

· Neurodegeneration

· Cell Signaling Assays

· Drug Discovery & Screening

· Optogenetics

· Cre-inducible tools

· Custom packaging in viral vectors

· iPS-derived cell assays

About MoBiTec GmbH

MoBiTec GmbH (Goettingen, Germany) is a privately held company (founded in 1987) that offers research tools for molecular and cell biology. Products include DNA vectors for cloning and expression, cell transfection reagents and cell culture tools, immobilized and soluble enzymes, products for genomics and proteomics research, numerous antibodies and recombinant proteins, superior fluorescence reagents and kits, affinity chromatography products, as well as general laboratory equipment.

In parallel to its own product lines, MoBiTec distributes products from international companies in Germany. MoBiTec products are distributed worldwide, in Germany from their home office, in other countries by distributors.

MoBiTec GmbH, Lotzestr. 22a, 37083 Goettingen,
Germany, info@mobitec.com, www.mobitec.com

This release was published on openPR.